Senior operating executive and investor focused on growth-stage technology and consumer businesses. Combines operating experience in product and go-to-market leadership with direct investing and board roles across software and e-commerce portfolios. David Skalicky is known for hands-on scaling of commercial teams, transaction experience in M&A and capital raises, and supporting founder-led management on strategy, metrics, and operational execution.
Senior operating executive and investor focused on growth-stage technology and consumer businesses. Combines operating experience in product and go-to-market leadership with direct investing and board roles across software and e-commerce portfolios. David Skalicky is known for hands-on scaling of commercial teams, transaction experience in M&A and capital raises, and supporting founder-led management on strategy, metrics, and operational execution.
Focuses on growth-stage technology and consumer opportunities, deploying capital to companies where product-market fit exists and commercial scaling is the primary value driver. Prefers concentrated, board-level positions enabling hands-on go-to-market and product leadership, KPI-driven operational playbooks, and follow-on funding to de-risk execution. Investment horizon is multi-year, emphasizing revenue fundamentals, unit economics, and repeatable sales motions. Risk discipline centers on staged capital, clear milestone gating, and founder alignment.
Focuses on growth-stage technology and consumer opportunities, deploying capital to companies where product-market fit exists and commercial scaling is the primary value driver. Prefers concentrated, board-level positions enabling hands-on go-to-market and product leadership, KPI-driven operational playbooks, and follow-on funding to de-risk execution. Investment horizon is multi-year, emphasizing revenue fundamentals, unit economics, and repeatable sales motions. Risk discipline centers on staged capital, clear milestone gating, and founder alignment.
| Trades 1017 | Longs Won 689/1017 67% | Profit Factor 4.16 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $412,627.46 |
| Average Win $266,694.03 | Best Trade (Oct 14) $4.95M | Sharpe Ratio -16.18 |
| Average Loss -$134,528.36 | Worst Trade (Dec 31) -$1.4M | Z-Score 11.06 (100%) |
| Commissions $0 | Avg. Trade Length 1y 5m 2w 5d | Expectancy $137,292.91 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 5,435 | 4,891 | 4,348 | 3,804 | 3,261 | 2,717 | 2,174 | 1,630 | 1,087 | 543 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 68,052 | $14.72M | $23.32M | - | $8.59M | 58.36% | -0.096% |
AGG iShares Core U.S. Aggregate Bond ETF | 4,486 | $434,693 | $427,874.68 | - | -$6,818.32 | -1.57% | +0.591% |
AMT American Tower Corporation | 14,400 | $2.81M | $2.6M | - | -$203,459.23 | -7.25% | +0.828% |
AMZN Amazon.com Inc | 44,816 | $9.09M | $11.44M | - | $2.34M | 25.77% | +0.443% |
APH Amphenol Corporation | 128,112 | $5.65M | $10.45M | - | $4.81M | 85.12% | -1.318% |
APTV Aptiv PLC | 60,000 | $3.76M | $2.72M | - | -$1.05M | -27.87% | +3.251% |
ARES Ares Management Corporation | 10,500 | $1.15M | $1.2M | - | $52,395 | 4.57% | +1.422% |
AVGO Broadcom Inc. | 54,689 | $10.6M | $18.84M | - | $8.24M | 77.73% | -0.5% |
B BARRICK MINING CORP Common Stock (ABR0) | 50,700 | $1.06M | $2.06M | - | $1M | 94.79% | +4.281% |
BA Boeing Company | 25,500 | $4.82M | $4.8M | - | -$26,376 | -0.55% | +1.901% |
BABA Alibaba Group Holding Limited SP ADR | 34,000 | $3.26M | $3.77M | - | $509,660 | 15.62% | -0.18% |
BALL Ball Corp. | 67,000 | $3.95M | $4.21M | - | $255,838 | 6.47% | +3.938% |
BIIB Biogen Inc. | 20,000 | $3.63M | $4.74M | - | $1.11M | 30.74% | +1.843% |
BKNG Booking Holdings Inc. | 35,125 | $6.32M | $5.85M | - | -$471,082.35 | -7.46% | +3.61% |
BLK BlackRock, Inc. | 4,100 | $3.94M | $4.59M | - | $647,319.66 | 16.42% | +4.264% |
BMY Bristol-Myers Squibb Company | 130,000 | $6.44M | $7.92M | - | $1.48M | 22.91% | +2.733% |
BRK-B Berkshire Hathaway Inc. | 13,200 | $5.93M | $6.95M | - | $1.03M | 17.34% | +0.079% |
BX Blackstone Inc. | 11,700 | $1.35M | $1.28M | - | -$61,191 | -4.55% | +3.342% |
C Citigroup Inc. | 67,000 | $4.17M | $8.26M | - | $4.09M | 98.05% | +0.769% |
CB Chubb Limited | 32,100 | $9.12M | $11.34M | - | $2.22M | 24.38% | +0.902% |